Among the grants approved by the Board recently were four TB grants and one TB/HIV grant to India. In this article, we report on the comments from the Technical Review Panel (TRP) and the Grants Approvals Committee (GAC) on the funding request from which these grants emanated.
When it reviewed India’s HIV funding request in 2017, the Technical Review Panel (TRP) commended the Government of India for its ambitious plan to fast track the end of the HIV epidemic. At the same time, however, the TRP raised concerns about what it viewed as the request’s failure to include a focus on human rights and gender.
TRP praises Kenya's TB/HIV funding request to the Global Fund for its sensitivity to key populations and human rights
Nigeria’s grant portfolio continues to provide plenty of drama.
TRP provides comments on requests submitted to the Global Fund in the first two windows of 2017-2019
Philippines’ HIV funding request to the Global Fund contains a good mix of prevention and treatment: TRP
The Philippines’ HIV funding request was strategically focused with appropriately targeted investments towards HIV prevention programs for key populations, and access to testing and treatment services. This was the conclusion of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) when they reviewed the request.
TRP praises Uganda’s TB/HIV funding request to the Global Fund, but sends two matching funds requests back for iteration
In its review of Uganda’s TB/HIV funding request, the Technical Review Panel (TRP) praised the country for positioning the request as part of a more sustainable response, including a push to improve coordination with the private sector, and for scaling up interventions for key populations.
Bangladesh’s “ambitious, but realistic” TB funding request to the Global Fund receives positive reviews
The TB funding request submitted by the Bangladesh CCM received positive reviews from the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). The two grants emanating from the request were approved by the Board on 17 October. A total of $110.9 million was approved, reflecting the total TB allocation for Bangladesh of $97.9 million and an additional $13.0 million in catalytic matching funds.
Global Fund expresses concern over Benin’s plan to shift funds away from HIV and malaria towards an RSSH funding request
When it reviewed the funding requests from Benin, the Grant Approvals Committee (GAC) and the Technical Review Panel (TRP) expressed serious concerns about what they perceived as gaps in Benin’s HIV and malaria programs – which, they said, were partly due to the decision of the country coordinating mechanism (CCM) to shift some of its allocation towards an RSSH funding request.
The original allocation for Benin was as follows:
The two TB/HIV grants to Malawi which the Board approved on 17 October do not differ significantly from the funding request, which was submitted on 20 March 2017. GFO detailed the contents of the request in an article in GFO 316 on 19 July.